Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
A decision is expected by August 17, 2026 under the Prescription Drug User Fee Act timeline
The programme integrates simulation-based training, expert-led sessions, and case-based discussions
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
Subscribe To Our Newsletter & Stay Updated
